AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Spanish Prospective Registry of Hydra THV for Transcatheter Aortic Valve Implantation

Recruitingn/aAges 18 Years - anyAllFundación EPIC
💬

In plain words

What the trial is, and whether it could suit you

This study is designed to evaluate the success rate of transfemoral implantation of the Hydra THV biological aortic valve prosthesis in patients with severe symptomatic aortic stenosis. The device is used in accordance with its Instructions for Use as a CE-marked transcatheter heart valve system. The study will assess procedural success, device performance, and early clinical outcomes following implantation. Patients undergoing transcatheter aortic valve replacement (TAVR) via the transfemoral approach will be followed to evaluate safety and effectiveness outcomes, including short- and mid-term clinical follow-up.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: Participants who meet ALL of the following conditions will be included: * Age ≥ 18 years and; * Severe aortic stenosis with indication for aortic valve replacement in which a Hydra THV device is implanted according to the instructions for use; and * Signed informed consent. Exclusion Criteria: Patients who do NOT meet ANY of the following conditions will be included: * Express refusal by the participant to participate in the study. * Aortic stenosis patients who are not candidates for Hydra THV device implantation or in whom implantation of this device is performed for an indication other than aortic stenosis (especially pure native aortic valve insufficiency). Patients in whom the Hydra THV device is implanted to treat patients with degenerated aortic bioprostheses may be included in the study. * Participants in randomised clinical trials who have not reached the research endpoint. * Pregnant and/or breastfeeding women.
💊

What it tests

  • Hydra THV
📍

Where

7 sites
Hospital Clínico San Carlos
Aravaca, Spain
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Hospital Universitario La Paz
Fuencarral-El Pardo, Spain
Hospital Universitari de Salamanca
Salamanca, Spain
Hospital Clínico Universitario de Santiago
Santiago de Compostela, Spain
Hospital Universitario Virgen del Rocio
Seville, Spain
Hospital General Universitario de Toledo
Toledo, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy